Technetium-99m-Tetrofosmin Myocardial Imaging: A Comparison with Thallium-201 and
Angiography Page 1 (CAD) (1). Indeed, this technique, primarily developed using 20111,has …

Technetium-99m tetrofosmin is a new myocardial imaging agent with improved handling
and kinetic characteristics. The purpose of this study was to compare the ability of planar …

This study compared the results of planar and single-photon emission computed
tomographic (SPECT) imaging with tetrofosmin with those of 201 Tl and coronary …

Background. Technetium 99m-labeled myocardial agents have been proposed as an
alternative to thallium 201. The aim of this study was to assess retrospectively the accuracy …

From the Department ofNuclear Medicine and Division ofCardiology, HÃpitalHÃtel-Dieu de
Montré al, Université de Montré al, Montré al, Canada mill stress tests with 201T1 …

Background. Technetium 99m-labeled sestamibi and tetrofosmin tomography have shown
high diagnostic accuracy in the detection of coronary artery disease (CAD). However, few …

Abstract Technetium-99m (To-99m) tetrofosmin, a new myocardial perfusion imaging agent,
was evaluated at exercise and rest in 50 patients with documented coronary artery disease …

Technetium-99m tetrofosmin is a new myocardial perfusion imaging agent that accumulates
rapidly and shows slow clearance from the myocardium. Dynamic acquisition and SPECT …

Subjects and Patients with Coronary Artery Disease Page 1 Myocardial Technetium-99m-Tetrofosmin
and Technetium-99m-Sestamibi Kinetics in Normal Subjects and Patients with Coronary Artery …

The two new 99m (99mTc) labeled myocardial perfusion agents, 99mTc-Sestamibi and
99mTc-Teboroxime, are now available for routine clinical application. Both agents allow …